Unknown

Dataset Information

0

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.


ABSTRACT: The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most effective vaccines available, with a 65-yr history of use in >400 million people globally. Despite this efficacy, there is presently no information about the immunological mechanisms by which YF-17D acts. Here, we present data that suggest that YF-17D activates multiple Toll-like receptors (TLRs) on dendritic cells (DCs) to elicit a broad spectrum of innate and adaptive immune responses. Specifically, YF-17D activates multiple DC subsets via TLRs 2, 7, 8, and 9 to elicit the proinflammatory cytokines interleukin (IL)-12p40, IL-6, and interferon-alpha. Interestingly, the resulting adaptive immune responses are characterized by a mixed T helper cell (Th)1/Th2 cytokine profile and antigen-specific CD8+ T cells. Furthermore, distinct TLRs appear to differentially control the Th1/Th2 balance; thus, whilst MyD88-deficient mice show a profound impairment of Th1 cytokines, TLR2-deficient mice show greatly enhanced Th1 and Tc1 responses to YF-17D. Together, these data enhance our understanding of the molecular mechanism of action of YF-17D, and highlight the potential of vaccination strategies that use combinations of different TLR ligands to stimulate polyvalent immune responses.

SUBMITTER: Querec T 

PROVIDER: S-EPMC2118210 | biostudies-literature | 2006 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.

Querec Troy T   Bennouna Soumaya S   Alkan Sefik S   Laouar Yasmina Y   Gorden Keith K   Flavell Richard R   Akira Shizuo S   Ahmed Rafi R   Pulendran Bali B  

The Journal of experimental medicine 20060206 2


The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most effective vaccines available, with a 65-yr history of use in >400 million people globally. Despite this efficacy, there is presently no information about the immunological mechanisms by which YF-17D acts. Here, we present data that suggest that YF-17D activates multiple Toll-like receptors (TLRs) on dendritic cells (DCs) to elicit a broad spectrum of innate and adaptive immune responses. Specifically, YF-17D activates multi  ...[more]

Similar Datasets

| S-EPMC7697718 | biostudies-literature
| S-EPMC4757529 | biostudies-literature
2008-12-01 | GSE13699 | GEO
2017-06-25 | GSE82152 | GEO
2020-05-19 | GSE136163 | GEO
| S-EPMC4896586 | biostudies-other
| S-EPMC7564786 | biostudies-literature
| S-EPMC4071376 | biostudies-literature
| S-EPMC3167859 | biostudies-literature
| S-EPMC6896426 | biostudies-literature